Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Kenneth Hoberman Insider Profile
4 Followers
Kenneth Hoberman, COO at Stemline Therapeutics, holds 242.69K shares in TG Therapeutics (Ticker: TGTX), holds 73.14K shares in Nuvectis Pharma (Ticker: NVCT), holds 0.00 shares in Stemline Therapeutics (Ticker: STML).
Profitable Transactions
16 out of 23 Profitable Transactions
Average Return
-0.90%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Kenneth Hoberman holds in companies
Most Profitable Insider Trade
Stock:
Stemline Therapeutics
(STML)
(STML)
Rating:Informative Sell
Date:Feb 20, 2015 - Feb 20, 2016
Return:+70.20%
The most profitable trade made by Kenneth Hoberman
Kenneth Hoberman's Trading History
Stemline Therapeutics
Jun 10, 2020
―
Uninformative Sell
―
$0.00
Nuvectis Pharma
Jun 20, 2023
Director
Uninformative Buy
―
$494.43K
TG Therapeutics
Sep 29, 2023
Director
Uninformative Buy
―
$3.35M
List of latest transactions for each holding click on a transaction to see Kenneth Hoberman's performance on stock
You May Also Like
Kenneth Hoberman insider profile FAQ
What is the percentage of profitable transactions made by Kenneth Hoberman?
The percentage of profitable transactions made by Kenneth Hoberman is 70%.
What is the average return per transaction made by Kenneth Hoberman?
The average return per transaction made by Kenneth Hoberman is -0.90%.
What stocks does Kenneth Hoberman hold?
Kenneth Hoberman holds: STML, NVCT, TGTX stocks.
What was Kenneth Hoberman’s latest transaction?
Kenneth Hoberman latest transaction was an Uninformative Buy of ―.
What was Kenneth Hoberman's most profitable transaction?
Kenneth Hoberman’s most profitable transaction was an Informative Sell of STML stock on February 20, 2015. The return on the trade was 70.20%.
What is Kenneth Hoberman's role in Stemline Therapeutics?
Kenneth Hoberman's role in Stemline Therapeutics is COO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.